140 related articles for article (PubMed ID: 26083214)
61. Thalidomide for the treatment of recalcitrant oral Crohn's disease and orofacial granulomatosis.
Hegarty A; Hodgson T; Porter S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 May; 95(5):576-85. PubMed ID: 12738949
[TBL] [Abstract][Full Text] [Related]
62. Successful methotrexate treatment of oesophageal pemphigus vulgaris in an immunosuppressed patient with Crohn's disease.
Horváth ON; Borovaya A; Roider E; Klose J; Hartlieb E; Waschke J; Ruzicka T; Sárdy M
Acta Derm Venereol; 2015 Sep; 95(7):868-9. PubMed ID: 25708196
[No Abstract] [Full Text] [Related]
63. Drug treatment for Crohn's disease.
Yacyshyn BR
Lancet; 1998 Aug; 352(9129):743. PubMed ID: 9729027
[No Abstract] [Full Text] [Related]
64. Basiliximab and infliximab for the treatment of steroid-refractory Crohn's disease.
Price M; Probert CS; Creed T
Am J Gastroenterol; 2008 Oct; 103(10):2665. PubMed ID: 18855871
[No Abstract] [Full Text] [Related]
65. 6-Mercaptopurine/Azathioprine remains an important contributor in managing Crohn's disease.
Korelitz BI; Present DH
J Crohns Colitis; 2014 Aug; 8(8):735-8. PubMed ID: 24462321
[TBL] [Abstract][Full Text] [Related]
66. THERAPIES FOR CROHN'S DISEASE: a clinical update.
Sobrado CW; Leal RF; Sobrado LF
Arq Gastroenterol; 2016; 53(3):206-11. PubMed ID: 27438429
[TBL] [Abstract][Full Text] [Related]
67. [Clinical picture and therapy of regional enteritis (Crohn's disease)].
Kasper H
Dtsch Med Wochenschr; 1972 May; 97(21):844-9. PubMed ID: 4555330
[No Abstract] [Full Text] [Related]
68. Adalimumab: new indication. Severe Crohn's disease: a second TNF alpha antagonist, subcutaneous administration.
Prescrire Int; 2008 Aug; 17(96):137. PubMed ID: 19480092
[No Abstract] [Full Text] [Related]
69. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease.
Peyrin-Biroulet L; Oussalah A; Williet N; Pillot C; Bresler L; Bigard MA
Gut; 2011 Jul; 60(7):930-6. PubMed ID: 21228429
[TBL] [Abstract][Full Text] [Related]
70. Spot diagnosis: eruptive melanocytic naevi during azathioprine therapy in Crohn's disease.
Wonders J; De Boer NK; Van Weyenberg SJ
J Crohns Colitis; 2012 Jun; 6(5):636. PubMed ID: 22402255
[No Abstract] [Full Text] [Related]
71. Safety and efficacy of intravenous cyclophosphamide pulse therapy in therapy refractory Crohn's disease patients.
Hirschmann S; Atreya R; Englbrecht M; Neurath MF
J Physiol Pharmacol; 2017 Feb; 68(1):57-67. PubMed ID: 28456770
[TBL] [Abstract][Full Text] [Related]
72. Mongersen and SMAD-7 Inhibition, Not a Lucky 7 for Patients With IBD: When Trial Design Is as Important as Disease Therapy.
Bewtra M; Lichtenstein GR
Am J Gastroenterol; 2020 May; 115(5):687-688. PubMed ID: 32195732
[TBL] [Abstract][Full Text] [Related]
73. [Treatment of Crohn's disease: step-up or top-down?].
Herrlinger K; Stange EF
Dtsch Med Wochenschr; 2010 Aug; 135(34-35):1694-8. PubMed ID: 20721847
[No Abstract] [Full Text] [Related]
74. [A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators].
Martreau P
Gastroenterol Clin Biol; 2000 Dec; 24(12):1243-4. PubMed ID: 11277090
[No Abstract] [Full Text] [Related]
75. Successful treatment of metastatic Crohn's disease with cyclosporine.
Carranza DC; Young L
J Drugs Dermatol; 2008 Aug; 7(8):789-91. PubMed ID: 18720698
[TBL] [Abstract][Full Text] [Related]
76. [Medical management of pediatric Crohn's disease].
Zeng Y; Gong S
Zhonghua Er Ke Za Zhi; 2014 May; 52(5):345-8. PubMed ID: 24969931
[No Abstract] [Full Text] [Related]
77. Early use of azathioprine in Crohn's disease.
Hawthorne AB; Probert CS; Sanderson JD
Gastroenterology; 2014 Mar; 146(3):865-6. PubMed ID: 24468182
[No Abstract] [Full Text] [Related]
78. [Osteomyelitis sicca in Crohn disease--coincidence or extraintestinal manifestation?].
Folwaczny C; Folwaczny M; Winter WA; Daschner H; Heldwein W; Loeschke K
Z Gastroenterol; 1996 Oct; 34(10):704-7. PubMed ID: 9012224
[TBL] [Abstract][Full Text] [Related]
79. [Immunosuppressive treatment of Crohn's disease].
Kasper H; Auer I
Dtsch Z Verdau Stoffwechselkr; 1976; 36(3-4):143-5. PubMed ID: 1021382
[No Abstract] [Full Text] [Related]
80. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
Nathan DM; Iser JH; Gibson PR
J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
